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Lisa Muirhead, DNP, APRN, ANP-BCBackgroundThere is strong evidence to suggest that adultsliving with serious mental illness have a higherrisk of mortality and morbidity than the general
U.S. population, including a higher risk of mortality
associated with certain cancers and cancer-related
deaths.1–5 The potential loss of life expectancy among
this population may be as high as 25 years compared to
those without a mental illness.1,3,6 There are numerous
challenges faced by people with serious mental illness,
and behavioral factors that may contribute to increased
cancer risk, including high prevalence of smoking,
obesity, physical inactivity, substance abuse, and infec-
tious diseases.2,4,7–9 Many of these individuals are unin-
sured, homeless, have a dual diagnosis of substance
abuse, and are least likely to10 access and use preventive
healthcare services.1,3,11 There is growing concern that
those with serious mental illness experience disparities in
health education, health prevention services, cancer
screening, access to diagnostic testing, cancer case
recognition, and higher cancer case fatalities.4,9 Although
there are many interrelated and complex factors asso-
ciated with cancer-related risk among this vulnerable
population, many of these factors can be addressed.3 This
paper aims to increase awareness of cancer risk factors
and implications of employing innovative health promo-
tion and cancer-prevention strategies among people with
serious mental illness.
Introduction
Health disparities among those with mental illness
constitute a major public health problem in the U.S.
Nationwide, one in four adults live with a mental
illness.12 The impact of mental disorders on the lives of
individuals varies from minor functional impairments to
widespread incapacitation in daily and social abilities,
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Open access under CC BY-NC-ND license.population, adults with serious mental illness (including
schizophrenia, bipolar disorder, or major depression)
experience disparities in education, income, employ-
ment, housing, healthcare service use, community
engagement, and life span.15–17 Even within racial and
ethnic groups, disparities exist in duration of course of
illness, treatment modalities, disability associated with
serious mental illness, and access to mental health
services.14,18 Although many adults living with serious
mental illness are uninsured, 2012 estimates from the
USDHHS indicate that 11 million new beneﬁciaries of
the Affordable Care Act will be eligible for and need
mental health and substance abuse services.
People with serious mental illness receive fewer
preventive services and poorer access to high-quality
medical care.19,20 These patients often resort to using
emergency services; they experience difﬁculty communi-
cating with providers and across systems, scheduling
appointments, and navigating health systems.15,21,22
Even within healthcare systems, cognitive, behavioral,
and social limitations associated with serious mental
illness may contribute to primary care providers’ difﬁ-
culties in obtaining medical histories and planning care.
This population also experiences difﬁculty adhering to
medical regimens and faces challenges in obtaining and
maintaining insurance for medical services.22 Patient
factors such as distrust and lack of motivation make
adherence difﬁcult.13,23 Additionally, somatic complaints
may be attributed to the psychiatric disorders, potentially
resulting in underestimation of the care needed. Patients
with co-occurring serious mental illness and substance
use disorders often experience even greater challenges
because as the morbidity associated with mental disor-
ders increases, receipt of preventive care services tends to
decrease.22
Those living with serious mental illness also experi-
ence higher rates of mortality and morbidity than the
general population from cardiovascular disease, respira-
tory disease, diabetes, some cancers, and infectious
diseases.6,15,23–25 Excess mortality from laryngeal, hep-
atobiliary, and urinary tract cancers has been reported
among this vulnerable population. This increase in death
rates has been attributed to high prevalence of smoking,
substance abuse, and chronic hepatic infections such as
hepatitis B and C.4 Lung, pharyngeal, and gallbladderlsevier Inc. on behalf of American Journal of Preventive Medicine
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with schizophrenia than the general population.7 Risk
factors related to the higher incidences in these cancers
among people with schizophrenia are associated with
tobacco and alcohol use, obesity, and high-fat diets.
Other studies have shown that although the incidence
of cancer among those with mental illness is no higher
than the general population, the likelihood of advanced
staging at the time of diagnosis is greater.8,7 This may be
explained by inequities in cancer screening, access to
care, reduced amount of specialty intervention, and delay
of appropriate treatment following cancer diagnosis.8,9
In the eight-state study on congruencies in increased
mortality rates, years of potential life lost, and causes of
death among public mental health clients, the relative
risk of death was higher in all eight states (Arizona,
Missouri, Oklahoma, Rhode Island, Texas, Utah,
Vermont, and Virginia).2 The leading cause of death in
public mental health clients mirrored the general pop-
ulation, including heart disease, cancer, cerebrovascular
disease, and pulmonary disease. Cancer ranked as the
second highest cause of mortality in three states.2,23 A
Maryland study involving Medicaid adult beneﬁciaries
with bipolar disorders and schizophrenia revealed an
increased incidence in lung, colorectal, and breast cancer.
The complex interrelatedness among seriousmental illness,
its relative social consequences, and cancer risk has
important implications for prevention efforts.20,26 Cigarette
smoking, excessive body weight, infectious diseases, and
increased prevalence of alcohol and substance use are
major contributors to higher rates of poorer health out-
comes associated with malignancies and chronic diseases
among this vulnerable population.15,23,24,27
Key Risk Factors
Tobacco Use
Cigarette smoking, a leading cause of preventable disease
and death, has been associated with an estimated $96
billion in medical expenses and loss of productivity.28
Tobacco use among individuals with serious mental
illness contributes to development of cancer, respiratory
disease, and cardiovascular disease and to worsening of
other chronic conditions.29 There is evidence of increas-
ing tobacco-related cancers.30 The single largest contrib-
utor to cancer worldwide is considered to be tobacco
smoking.30 Cancer of the lungs, larynx, bronchus, and
trachea has been attributed to smoking.4,31 Despite the
known adverse health effects of smoking, rates of tobacco
use are high in those with serious mental illness, with
almost half of all adults in this population smoking
cigarettes.15,22,23,27,28,32–36 Data from the 2009–2011
National Survey on Drug Use and Health (NSDUH)28March 2014indicated that 30.9% of all tobacco consumed from
cigarette smoking among adults is attributable to con-
sumption among those with serious mental illness. The
highest prevalence of cigarette smoking among adults
with mental illness was among men, those aged o45
years, those living below the poverty level, and those with
less education. Although smoking rates among this
vulnerable population were highest for those aged 18–
24 (41.6%), smoking rates were also high among those
aged 45–64 years (33.5%). The NSDUH did not include
individuals living in mental health residential commun-
ities and individuals in the military, where rates could be
higher. Additionally, individuals with schizophrenia have
even higher rates of cigarette smoking and tend to have
greater nicotine dependence and extraction.27,35,37 Prev-
alence of cigarette smoking among individuals with
schizophrenia may be as high as 90% compared to the
general population, where smoking rates are between
20% and 25%.35,38 In this population, cigarette smoking
may be used as a way to improve cognitive function and
self-management of symptoms associated with mental
illness.27,28,39 However, cigarette smoking can be an
impediment in reaching therapeutic levels of certain
medications used to treat some mental disorders.33,40
Compounding the problems associated with tobacco
use, many adults with serious mental illness are in stressful
and unstable living situations, have inadequate ﬁnancial
resources, are poorly informed of deleterious health effects
of smoking, lack access to smoking-cessation treatment,
and may experience greater difﬁculty with withdrawal
symptoms.28,41,42 Cessation programs are infrequently
offered and underutilized among individuals with serious
mental illness, and smoke quit rates are lower among this
population. Thus, tailored and sustainable strategies to
mitigate smoking or improve smoking cessation must be
employed and may be the single most important inter-
vention to reduce speciﬁc cancer risk among this vulner-
able population.4,27,31,33,38,40Obesity
Excessive body weight is associated with increased risk of
mortality from multiple cancers.43 Higher rates of cancer
of the esophagus, colorectum, breast, endometrium, and
kidneys are associated with obesity and being over-
weight.4,44 Researchers found that higher rates of death
for all cancers combined at multiple speciﬁc sites were
associated with an increase in body weight among both
genders.43 As the prevalence of obesity among the
general population has risen to epidemic proportions,
the prevalence of overweight and obese adults with
serious mental illness has also increased and has
exceeded rates in the general population.45–48 Physical
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with antipsychotic medications, and symptomatology
associated with speciﬁc mental disorders contribute to
the high rates of obesity in people with serious mental
illness.15,45,47–50 Physical activity among individuals with
serious mental illness tends to be lower than in the
general population,51,52 probably because of a lack of
social support, lethargy, and frequent illness. Lower levels
of self-efﬁcacy may be higher among women with serious
mental illness.52,53 Factors such as tobacco use and being
overweight may also contribute to lower levels of physical
activity in adults with bipolar disorders.47
Weight Gain
Dietary choices also contribute to obesity in this pop-
ulation. Although dietary habits vary among people with
mental illness, there are many factors associated with
weight gain. Excessive carbohydrate consumption
including sweetened beverages, comorbid binge eating
behaviors, use of medications with known weight gain
side effects, and having frequent and prolonged depres-
sive episodes contribute to higher risk of obesity.46,54,55
In a small pilot study, diets high in sugar consumption
were seen in patients with schizophrenia treated with
certain antipsychotic medication.56 A larger (N¼146)
study including dietary recall of patients with schizo-
phrenia found that their dietary selection was similar to
that of the general population, but they consumed larger
quantities of the same foods and thus more calories.57
Researchers in Scotland found that patients with schiz-
ophrenia consumed lower levels of ﬁber, fruits, and
vegetables and higher levels of saturated fats.58
A body of knowledge regarding weight gain, lipid
abnormalities, and hyperglycemia associated with the use
of second-generation antipsychotics has also been
amassed.15,53,59 These antipsychotic medications are the
most prescribed medications for schizophrenia.60 They
are usually selected for their reduced risk of neurologic
side effects in patients, thus reducing medication non-
adherence and stigmatization.53,59 Weight gain is a
common side effect of taking antipsychotic medication.
The pattern of weight gain varies among different
second-generation antipsychotics, ranging from 15 to
26 pounds during 1 year of treatment. These side effects
have been attributed to increase rates of morbidity and
inﬂuence patients’ adherence and discontinuation of use
despite their effectiveness.51,60 Focus groups consisting of
veterans with schizophrenia and schizoaffective disorder
indicated that they valued weight management and
appearance but thought that taking antipsychotic med-
ications made it even more difﬁcult to lose weight.
Patients identiﬁed increase in appetite, low energy, and
clumsiness as side effects contributing to a lack of weightloss. Fast-food advertising, accessible food delivery, lack
of portion control, irregular meals, unhealthy food
choices, and residential barriers that undermined weight
loss initiatives were also identiﬁed as obstacles to weight
loss.61Alcohol and Substance Use
Approximately 5.2 million adults have coexisting mental
health and addiction disorders.16,62 According to the
National Institute on Drug Abuse, co-occurrence of
mental illness and drug abuse is highly prevalent and
may derive from common predisposing factors such as
overlapping genetic factors, environmental triggers, and
similar brain regions affected by both disorders.62 Results
from the Epidemiologic Catchment Area study indicated
that there were high rates of alcohol and other substance
use among those with mental illness. Among 20,291
participants aged 18 and older, 37% of those with an
alcohol disorder had a mental disorder, and 53% of those
with a drug dependence disorder (other than alcohol)
were found to also have a mental disorder. This study
also revealed that people with one addictive disorder had
a seven times greater risk than the general population of
having another drug-related disorder.63
Findings from the National Epidemiologic Survey on
Alcohol and Related Conditions showed high self-
reported prevalence rates of psychotic disorders among
those with substance use disorders compared to those
without.64 Co-occurring mental illness and substance use
can lead to poor self-care, physical comorbidities, acci-
dents, increased sexual behavior,15,65 and increased risk
of cancers associated with excessive alcohol consumption
and viral infections.44,66,67 Evidence suggests that regular
alcohol consumption is a known cause of cancer second
to tobacco smoking, and has been linked to cancers of the
pharynx, larynx, oval cavity, esophagus, liver, colon,
rectum, and breast.68,69 The WHO International Agency
for Research on Cancer Monograph Working Group
reported that alcohol is an independent risk factor
associated with primary liver cancer.69Sleep
Sleep and circadian rhythm disruption among patients
with schizophrenia have been widely reported.70–74
Reports of patients with schizophrenia experiencing sleep
and circadian rhythm disruption have been as high as
30%–80%, depending on the extent of illness and
symptoms.70,75 Sleep disruptions can range from insom-
nia to courses of total sleeplessness.76 Reduction in sleep
time and sleep efﬁciency, increases in sleep latency, and
alteration in rapid eye movement sleep may occur in
patients with schizophrenia.73–75 Additionally, sleep inwww.ajpmonline.org
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less.76 Sleep disturbances may have a more profound
effect on people with schizophrenia, including altered
cognitive performance, impaired social and occupational
functioning, fragmented daytime sleep, anergia, excite-
ment, poor coping ability, and reduced quality of
life.70,71,75 There is strong evidence that obesity is a
major contributor to sleep apnea among those with
serious mental illness, and such disruption in sleep and
circadian rhythms can contribute to mood destabiliza-
tion.48,77 There is limited evidence to suggest that sleep
disturbances may also have a role in cancer risk, and that
disturbances in sleep may promote the predominance of
cancer-stimulatory cytokines, contributing to immune
suppression and cancer development.71,78 However,
evidence regarding the role of sleep disturbance in cancer
risk among those with serious mental illness is lacking.79
Homelessness
Adults with a serious mental illness have a greater risk
(25%–50%) of homelessness over a lifetime. This increase
in risk is 20 times that of the general population.81
Homelessness presents greater challenges for people with
serious mental illness and can further exacerbate cancer
risk–related factors.18,79–81 For example, homeless indi-
viduals have greater exposure to environmental elements,
inadequate nutrition, and higher rates of injury, heart
disease, liver disease, and other chronic conditions and
limited access to regular health care.19,80–85 Dispropor-
tionately high rates of hepatitis B and hepatitis C
infection have also been reported among the homeless
populations because of high-risk sexual behavior and
intravenous drug use,86–88 with rates as high as 17% to
31% for hepatitis B, and 17% to 53% for hepatitis C.89
Homelessness is also associated with certain cancer risk–
related behaviors. According to Chau et al.,83 there is an
increased prevalence of alcohol consumption, obesity,
greater sun exposure, increased outdoor time, and
increased number of sexual partners among women,
which placed them at greater risk for cervical cancer.
These issues compound the challenges for cancer-
prevention strategies among those with serious mental
illness and create a need for multiple system approaches.
Implications for Cancer Prevention
Individuals with serious mental illness are at increased
risk for chronic disease, different types of cancers, and
early death.6,15,23–25 This vulnerable population merits
quality care, equitable access, and innovative approaches
to cancer-prevention efforts that will enhance their
ability to live full, productive lives.15 In developing public
health strategies, racial and ethnic disparities, healthMarch 2014literacy, and difﬁculty navigating health systems should
also be considered.14,15,90 Although research has been
conducted to examine cancer causes and ways to prevent
various cancers, there is a need for parity in prevention
efforts between people with serious mental illness and the
general population. Thus far, there has been minimal
focus on cancer-prevention initiatives among this pop-
ulation, despite the alarmingly high rates of tobacco use,
alcohol consumption, obesity, viral infection, sleep dis-
turbances, and prolonged exposure to environmental
elements.
Approaches to address these risk factors may be
complex and require comprehensive community-
based mental health and evidence-based practices that
include coordination across government agencies, com-
munity centers, academic institutions, and the private
sector.15,27,33,40 Effective and innovative strategies to
build capacity among primary care and mental health
providers offer opportunities to meet the unique needs of
those experiencing serious mental illness.91 Cancer
prevention models utilizing interprofessional teams that
have been used for other groups with complex needs can
be tailored for those with serious mental illness, partic-
ularly those experiencing homelessness. Surveillance of
cancer rates among these vulnerable populations is also
warranted. Research to evaluate effective strategies to
prevent weight gain and to facilitate prevention and
cessation of alcohol and substance use in those with
serious mental illness must be developed.15,92 Robust and
sustained efforts are necessary for smoking-cessation
programs targeting this population.27,33,38,40 Increased
support to create and test cancer-prevention programs
among these vulnerable groups designed by community
partners and other stakeholders should be employed and
considered a public health priority that informs both
practice and policy.
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